Small but powerful: will nanoparticles be the future state-of-the-art therapy for IBD?

Introduction: Inflammatory bowel disease (IBD) is the inflammatory condition of the gastrointestinal tract particularly affecting the colon and the ileum. IBD patients can have a very poor quality of life because of the limited therapeutic efficacy and accompanied adverse effects.

Areas Covered: The potential ways to employ nanoparticles to deliver drugs to a certain site of inflammation are discussed.